Copyright © 2024 Research Nester. All Rights Reserved
Neuraminidase Inhibitors Drug Market size was over USD 98.04 billion in 2023 and is anticipated to cross USD 233.41 billion by 2036, witnessing more than 6.9% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of neuraminidase inhibitors drug is estimated at USD 103.45 billion.
This growth can be witnessed as a result of an increasing prevalence of influenza globally. Further, the advancement in the market and development of the drug is being focused upon by the companies. This will boost the market as well.
Growth Drivers
Increasing Awareness Among People
The government initiatives are increasing awareness among people with respect to influenza. This has enhanced the knowledge of people about the medicines and treatments that are available in the market for influenza. The neuraminidase inhibitors drug market is anticipated to grow as awareness is increasing further among people.
Rare Resistance Development
As the drug develops rare resistance to influenza, it has to be used in good quantity to achieve better results. Theprocess of resistance development is crucial to treat influenza. This is predicted to increase the demand for the drug resulting in an increase in the market growth as well.
Improving Infrastructure and Research Facilities
Development of infrastructural facilities as well as research and development is estimated to drive the neuraminidase inhibitors drug market growth of the drug. Several tests are conducted before a drug is used in treatments hence, excellent devices and facilities are required to complement the research and to achieve accurate results.
Opportunities
There is a lot of scope for the development in the field as drugs are being constantly improved with the help of technology and innovation. Companies are focusing on upgrading the drug and this presents an opportunity for the market to grow. Further, improving treatment, better equipment for disease detection, and hospital facilities are anticipated to increase the market demand.
Challenges
The neuraminidase inhibitors drug market may experience restriction in the growth since there are side effects of the drugs, for instance, vomiting, nausea, pain, and several others. This is predicted to result in a decrease in the demand for the drug and the growth of the market. Moreover, there still prevails lack of awareness among various regions and people are unaware of the disease as well as its cure.
|
Base Year |
2023 |
|
Forecast Year |
2024–2036 |
|
CAGR |
6.9% |
|
Base Year Market Size (2023) |
USD 98.04 billion |
|
Forecast Year Market Size (2036) |
USD 233.41 billion |
|
Regional Scope |
|
The neuraminidase inhibitors drug market is segmented by drug type, by route of administration, by distribution channel, and by region. On the basis of route of administration, the market is segmented into parenteral, nasal and oral. Under the route of administration segment, the oral sub- segment is anticipated to hold maximum share as people prefer the intake of the drug for treatment.
Our in-depth analysis of the global market includes the following segments:
|
By Drug Type |
|
|
By Route Of Administration |
|
|
By Distribution Channel |
|
On the basis of region-wise analysis, the neuraminidase inhibitors drug market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. The market in North America industry is set to dominate majority revenue share by 2036, as the region is highly developed since the technological advancement is rapid along with good infrastructure. This boosts the market growth as demand is estimated to rise. The market in the Asia pacific region is anticipated to grow as a result of rising cases of influenza in the region and the development is under process. Further, people are becoming aware of the disease and its treatment.
17 April, 2020:F. Hoffmann La Roche developed serology test for the detection of presence of COVID- 19 in humans who have been exposed to the disease. Antibody testing is crucial for testing people who do not show any symptoms of the disease.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?